ISHARES TR - U.S. PHARMA ETF (IHE)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / U.S. PHARMA ETF
Shares, excl. options Q3 2024
5.29M
Holdings value Q3 2024
$373M
Value change Q3 2024
-$36.5M
Grand Portfolio weight change Q3 2024
0%
Number of holders
141
Number of buys Q3 2024
58
Number of sells Q3 2024
-54
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 5.29M $373M -$36.5M $70.61 141
2024 Q2 5.82M $386M +$20.4M $66.32 141
2024 Q1 5.57M $378M +$225M $67.90 138
2023 Q4 2.04M $379M +$265M $185.40 132
2023 Q3 614K $109M -$4.55M $176.98 123
2023 Q2 641K $115M -$10.2M $179.11 115
2023 Q1 730K $128M -$5.31M $175.28 124
2022 Q4 747K $139M +$9.17M $186.13 126
2022 Q3 692K $117M -$7.42M $169.54 108
2022 Q2 747K $143M +$33.5M $191.65 119
2022 Q1 572K $111M +$8.97M $194.24 117
2021 Q4 521K $104M -$3.38M $199.66 106
2021 Q3 535K $98.1M +$981K $183.13 106
2021 Q2 529K $98.2M +$6.46M $185.74 98
2021 Q1 494K $87.8M -$2.28M $177.66 98
2020 Q4 506K $90.9M +$3.79M $179.44 97
2020 Q3 486K $79.5M -$9M $163.53 91
2020 Q2 544K $83.7M +$14.7M $153.87 88
2020 Q1 451K $60.7M -$20.5M $134.58 91
2019 Q4 599K $95.8M -$71.2M $160.11 91
2019 Q3 1.05M $147M +$43.8M $139.85 81
2019 Q2 732K $110M +$8.53M $150.79 83
2019 Q1 675K $104M -$235K $153.97 90
2018 Q4 684K $96.3M -$28.9M $140.75 93
2018 Q3 878K $147M -$70.6K $167.84 96
2018 Q2 876K $133M -$9.9M $151.35 90
2018 Q1 944K $139M -$139M $147.54 100
2017 Q4 1.85M $285M -$31.4M $154.38 106
2017 Q3 2.03M $317M -$32.6M $156.36 99
2017 Q2 2.24M $347M -$9.57M $155.13 92
2017 Q1 2.3M $348M +$60.4M $150.94 96
2016 Q4 1.95M $276M +$115M $141.42 92
2016 Q3 1.12M $167M -$45.9M $149.44 85
2016 Q2 1.36M $197M -$20.2M $144.40 88
2016 Q1 1.49M $205M -$77.7M $136.98 90
2015 Q4 1.92M $309M -$741K $161.69 102
2015 Q3 2.16M $321M -$24.1M $148.02 102
2015 Q2 2.31M $404M -$39.8M $174.82 118
2015 Q1 2.54M $437M +$86.7M $172.42 107
2014 Q4 2.05M $311M +$27.1M $151.40 101
2014 Q3 1.84M $259M -$10.4M $140.35 85
2014 Q2 1.92M $259M -$2.84M $135.11 86
2014 Q1 1.95M $247M +$26.5M $126.69 85